Relugolix Beneficial for Prostate Cancer Patients Undergoing Radiotherapy

FRIDAY, March 29, 2024-- For patients with localized and advanced prostate cancer receiving radiotherapy, relugolix achieves sustained castration, according to a study published online March 7 in JAMA Oncology.Daniel E. Spratt, M.D., from the...